News
Translational research
US drug firm licenses breakthrough Edinburgh cancer discovery
The University of Edinburgh and US biopharmaceutical company Nuvectis Pharma, Inc., have signed a multi-million-dollar licensing deal to turn a research breakthrough into new medicines for hard-to-treat cancers.
